PPIB and pneumonia: IMPORTANCE In this study, two novel P. aeruginosa phages, Bφ-R656 and Bφ-R1836, were evaluated in vitro, in silico, and in vivo for therapeutic efficacy and safety as an alternative antibacterial agent to control XDR-PA strains collected from pneumonia patients.